106854-77-7

Basic information

• Product Name: 1-BROMO-4-(2,2,2-TRIFLUOROETHOXY)BENZENE
• Synonyms: 1-BROMO-4-(2,2,2-TRIFLUOROETHOXY)BENZENE;UKRORGSYN-BB BBV-081072
• CAS NO: 106854-77-7
• Molecular Formula: C₈H₆BrF₃O
• Molecular Weight: 255.03
• Mol File: 106854-77-7.mol

Chemical Properties

• Boiling Point: 212.8±40.0 °C(Predicted)
• Appearance: /
• Density: 1.569±0.06 g/cm3(Predicted)
• Storage Temp.: Room temperature.
• CAS DataBase Reference: 1-BROMO-4-(2,2,2-TRIFLUOROETHOXY)BENZENE(CAS DataBase Reference)
• NIST Chemistry Reference: 1-BROMO-4-(2,2,2-TRIFLUOROETHOXY)BENZENE(106854-77-7)
• EPA Substance Registry System: 1-BROMO-4-(2,2,2-TRIFLUOROETHOXY)BENZENE(106854-77-7)

Safety Data

• Hazardous Substances Data: 106854-77-7(Hazardous Substances Data)

Usage

Uses

Used in Chemical Reactions and Organic Synthesis:
1-BROMO-4-(2,2,2-TRIFLUOROETHOXY)BENZENE is used as a reactant in various chemical reactions and organic synthesis processes, contributing to the formation of new compounds with diverse applications.
Used in Pharmaceutical Production:
In the pharmaceutical industry, 1-BROMO-4-(2,2,2-TRIFLUOROETHOXY)BENZENE is used as a building block for the development of new drugs. Its unique structure allows for the creation of molecules with specific therapeutic properties.
Used in Agrochemical Production:
1-BROMO-4-(2,2,2-TRIFLUOROETHOXY)BENZENE is also utilized in the agrochemical industry, where it serves as a precursor for the synthesis of various agrochemicals, such as pesticides and herbicides, to enhance crop protection and yield.
Used in Specialty Chemicals Production:
1-BROMO-4-(2,2,2-TRIFLUOROETHOXY)BENZENE is employed in the production of specialty chemicals, which are used in a wide range of applications, including coatings, adhesives, and materials for various industrial processes. Its unique properties make it a valuable component in the development of these specialized products.

Upstream product

• 57946-61-9 4-(2,2,2,-trifluoroethoxy)aniline 
• 106-41-2 4-bromo-phenol 
• 6226-25-1 2,2,2-trifluoroethyl trifluoromethanesulphonate 
• 25236-64-0 2,2,2-trifluoroethyl methanesulfonate 
• 95-56-7 2-hydroxybromobenzene 
• 433-06-7 2,2,2-Trifluoroethyl p-toluenesulfonate 
• 75-89-8 2,2,2-trifluoroethanol 
• 5467-74-3 4-Bromophenylboronic acid 
• 139139-81-4 bis(4-bromophenyl)iodonium triflate 
• 62149-35-3 1-(2,2,2-trifluoroethoxy)-4-nitrobenzene 

Downstream Products

• 823197-52-0 tert-butyl 4-[4-(2,2,2-trifluoroethoxy)phenyl]piperazine-1-carboxylate 
• 115171-04-5 4-(2,2,2-trifluoroethoxy)phenylhydrazine hydrochloride 
• 701270-59-9 tert-butyl 4-({6-[4-(2,2,2-trifluoroethoxy)phenyl]pyridin-3-yl}sulfonyl)tetrahydro-2H-pyran-4-carboxylate 
• 1416805-62-3 2-(2,4-Difluorophenyl)-1,1-difluoro-3-(1H-tetrazol-1-yl)-1-(6-(4-(2,2,2-trifluoroethoxy)phenyl)pyridin-3-yl)propan-2-ol 
• 1416805-85-0 2-(2,4-Difluorophenyl)-1,1-difluoro-3-(1H-tetrazol-1-yl)-1-(4'-(2,2,2-trifluoroethoxy)-[1,1'-biphenyl]-4-yl)propan-2-ol 
• 1416806-06-8 C₂₂H₁₄F₇NO₂ 
• 1416806-35-3 C₂₃H₁₅F₇O₂ 
• 886528-42-3 4,4,5,5-tetramethyl-2-(4-(2,2,2-trifluoroethoxy)phenyl)-1,3,2-dioxaborolane 
• 1340593-59-0 (2R)-2-(2,4-difluorophenyl)-1,1-difluoro-3-(1H-1,2,3,4-tetrazol-1-yl)-1-{5-[4-(2,2,2-trifluoroethoxy)phenyl]pyridin-2-yl}propan-2-ol 
• 1441066-70-1 C₂₂H₁₆F₆N₂O₂ 

Relevant articles and documents

HETEROCYCLIC COMPOUNDS AS DELTA-5 DESATURASE INHIBITORS AND METHODS OF USE

The present disclosure provides compounds useful for the inhibition of Delta-5 Desaturase ("D5D"). The compounds have a general Formula (I) wherein the variables of Formula (I) are defined herein. This disclosure also provides pharmaceutical compositions comprising the compounds, uses of the compounds, and compositions for treatment of, for example, a metabolic or cardiovascular disorder. Further, the disclosure provides intermediates useful in the synthesis of compounds of Formula (I).

HETEROCYCLIC COMPOUNDS AS DELTA-5 DESATURASE INHIBITORS AND METHODS OF USE

The present disclosure provides compounds useful for the inhibition of Delta-5 Desaturase ("D5D"). The compounds have a general Formula (I): wherein the variables of Formula (I) are defined herein. This disclosure also provides pharmaceutical compositions comprising the compounds, uses of the compounds, and compositions for treatment of, for example, a metabolic or cardiovascular disorder. Further, the disclosure provides intermediates useful in the synthesis of compounds of Formula (I).

Synthesis of trifluoroethyl aromatic compounds

The invention discloses a three-alkoxides the reference compound (A) synthetic method, is to potassium persulphate (B), trifluoro ethylsulfinate sodium sulfonate (C) and aromatic compound (D) as the raw material, in order to silver nitrate as the catalyst

Fungal lanosterol 14α-demethylase (CYP51) inhibitor Treatment of recurrent vulvovaginal candidiasis Treatment of onychomycosis

Developing a rationally designed, more selective azole antifungal agent that specifically targets the fungal CYP51 over the host CYP51 is a severe unmet need considering a massive shortfall in novel antifungal agents. In this context, oteseconazole (VT-1161) represents a very exciting new development targeting serious fungal infections caused by a wide variety of fungal pathogens including multidrug-resistant Candida responsible for recurrent vulvovaginal candidiasis. This monograph details the various in vitro and in vivo properties exhibited by oteseconazole as well as its current status in clinical trials.

Copper-catalyzed oxidative trifluoroethoxylation of aryl boronic acids with CF3CH2OH

A mild and efficient copper-catalyzed oxidative trifluoroethoxylation of aryl and heteroaryl boronic acids with CF3CH2OH has been developed. This protocol tolerates a range of functional groups, allowing access to a variety of aryl and heteroaryl trifluoroethyl ethers.

Method for preparing aryl trifluoroethoxyl ether

The invention relates to a method for preparing aryl trifluoroethoxyl ether. The method includes the steps that aryl boron compounds and trifluoroethanol are added to organic solvent, a copper salt catalyst, a ligand and an oxidizing agent are added, a reaction is conducted in a stirring mode for 1-40 hours at the temperature of 0-60 DEG C, filtering is conducted, column chromatography isolation is conducted, and the aryl trifluoroethoxyl ether is obtained. The method is simple in operation, raw materials are easy to obtain, the reaction condition is mild, the substrate universality is wide, the environmental friendliness is achieved, and the method is applicable to industrial application.

HETEROCYCLIC SULFONAMIDE DERIVATIVE AND MEDICINE COMPRISING SAME

The present invention provides a compound represented by the formula (I): wherein each symbol is as defined in the DESCRIPTION, or a pharmaceutically acceptable salt thereof. The compound has a superior TRPA1 antagonist activity, and can provide a medicament useful for the prophylaxis or treatment of diseases involving TRPA1 antagonist and TRPA1.

METALLOENZYME INHIBITOR COMPOUNDS

The present disclosure describes compounds having agricultural fungicidal activity.

METALLOENZYME INHIBITOR COMPOUNDS

The instant invention describes compounds having metalloenzyme modulating activity, and methods of treating diseases, disorders or symptoms thereof mediated by such metalloenzymes.